Trial intelligence / Profile preview

Evaluation of Intraoperative Tumor Margin Identification With Fluorescent Dye Imaging

NCT04719156Phase 2Recruiting

Start
Mar 2021
Primary completion
Dec 2026
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of indocyanine green in sarcoma. Started Mar 2021; status: recruiting.

02

Drugs

indocyanine green
03

Conditions

sarcoma

Beyond the preview

Go deeper on NCT04719156.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT04719156.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call